Connor, Clark & Lunn Investment Management (CC&L)
TERN icon

Connor, Clark & Lunn Investment Management (CC&L)’s Terns Pharmaceuticals TERN Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
2024
Q4 		$415K Buy
2024
Q3 		$442K Buy
2023
Q4 		– Sell
2023
Q3 		$342K Sell
2023
Q2 		$632K Buy
2023
Q1 		$142K Buy